Skip to content

Genprex, Inc.: 10-K filed 2023-03-31

What Genprex, Inc. reported in its annual report filed 2023-03-31 (fiscal FY 2022): 28 published measures, 106 facts as tagged in accession 0001437749-23-008847.

This filing

Form
10-K (annual report)
Filed
2023-03-31
Fiscal period
fiscal FY 2022
Accession
0001437749-23-008847 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Genprex, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2022-12-3125,085,027USD
At 2022-09-3029,945,826USD
At 2022-06-3034,565,123USD
At 2022-03-3139,409,431USD
At 2021-12-3142,862,286USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2022-09-302,457,311USD
At 2022-06-302,153,838USD
At 2022-03-312,384,817USD
At 2021-12-311,585,295USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2022-12-3122,274,740USD
At 2022-09-3027,488,515USD
At 2022-06-3032,411,285USD
At 2022-03-3137,024,614USD
At 2021-12-3141,276,991USD
At 2020-12-3130,916,490USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2022-01-01 to 2022-12-31-23,740,621USD365
2022-07-01 to 2022-09-30-6,142,562USD92
2022-01-01 to 2022-09-30-17,217,022USD273
2022-04-01 to 2022-06-30-5,764,642USD91
2022-01-01 to 2022-06-30-11,074,460USD181
2021-01-01 to 2021-12-31-20,664,969USD365
2021-01-01 to 2021-03-31-5,309,817USD90

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2022-01-01 to 2022-12-31-17,778,964USD365
2021-01-01 to 2021-12-31-14,284,924USD365

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2022-01-01 to 2022-12-310USD365
2021-01-01 to 2021-12-3131,700USD365

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2022-01-01 to 2022-12-310USD365
2022-07-01 to 2022-09-300USD92
2022-01-01 to 2022-09-300USD273
2022-04-01 to 2022-06-300USD91
2022-01-01 to 2022-06-300USD181
2021-01-01 to 2021-12-310USD365
2021-01-01 to 2021-03-310USD90

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2022-01-01 to 2022-12-316,426USD365
2021-01-01 to 2021-12-3125,677,911USD365

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2022-01-01 to 2022-12-3197,731USD365
2021-01-01 to 2021-12-31-83,796USD365

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2022-12-31-102,827,819USD
At 2022-09-30-96,304,220USD
At 2022-06-30-90,161,658USD
At 2022-03-31-84,397,015USD
At 2021-12-31-79,087,198USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2022-01-01 to 2022-12-3147,952,100shares365
2021-01-01 to 2021-12-3147,097,251shares365

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2022-01-01 to 2022-12-31-0.5USD/shares365
2022-07-01 to 2022-09-30-0.13USD/shares92
2022-01-01 to 2022-09-30-0.36USD/shares273
2022-04-01 to 2022-06-30-0.12USD/shares91
2022-01-01 to 2022-06-30-0.23USD/shares181
2021-01-01 to 2021-12-31-0.44USD/shares365
2021-01-01 to 2021-03-31-0.11USD/shares90

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2022-12-3123,032USD
At 2021-12-3148,608USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2022-01-01 to 2022-12-314,731,944USD365
2021-01-01 to 2021-12-315,347,559USD365

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2022-01-01 to 2022-12-31-23,830,719USD365
2022-07-01 to 2022-09-30-6,170,439USD92
2022-01-01 to 2022-09-30-17,251,522USD273
2022-04-01 to 2022-06-30-5,770,386USD91
2022-01-01 to 2022-06-30-11,081,083USD181
2021-01-01 to 2021-12-31-20,670,102USD365
2021-01-01 to 2021-03-31-5,310,696USD90

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2022-12-3121,473,145USD
At 2021-12-3139,140,224USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2022-12-312,810,287USD
At 2021-12-311,585,295USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2022-12-3134,852USD
At 2021-12-310USD

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2022-01-01 to 2022-12-3111,510,074USD365
2022-07-01 to 2022-09-303,157,731USD92
2022-01-01 to 2022-09-308,124,884USD273
2022-04-01 to 2022-06-302,926,927USD91
2022-01-01 to 2022-06-304,967,153USD181
2021-01-01 to 2021-12-318,970,865USD365
2021-01-01 to 2021-03-312,040,226USD90

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2022-12-3148,105,962shares
At 2021-12-3147,874,708shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2022-12-31125,054,453USD
At 2022-09-30123,744,715USD
At 2022-06-30122,525,045USD
At 2022-03-31121,373,750USD
At 2021-12-31120,316,315USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2022-12-31702,095USD
At 2021-12-31642,360USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2022-12-313,588,850USD
At 2021-12-313,673,454USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2022-12-31484,224USD
At 2021-12-31511,348USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2022-01-01 to 2022-12-3112,295,070USD365
2022-07-01 to 2022-09-303,006,484USD92
2022-01-01 to 2022-09-309,107,141USD273
2022-04-01 to 2022-06-302,836,916USD91
2022-01-01 to 2022-06-306,100,657USD181
2021-01-01 to 2021-12-3111,676,703USD365
2021-01-01 to 2021-03-313,263,741USD90

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2022-01-01 to 2022-12-3125,575USD365
2022-07-01 to 2022-09-306,224USD92
2022-01-01 to 2022-09-3019,497USD273
2022-04-01 to 2022-06-306,543USD91
2022-01-01 to 2022-06-3013,273USD181
2021-01-01 to 2021-12-3122,534USD365
2021-01-01 to 2021-03-316,730USD90

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2022-01-01 to 2022-12-316,426USD365
2021-01-01 to 2021-12-3125,677,911USD365

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2022-01-01 to 2022-12-3134,852USD365
2021-01-01 to 2021-12-31-127USD365

Inspect the source

Entity
Genprex, Inc. / CIK 0001595248
Captured
2026-09-20T09:24:36.735Z
SEC response SHA-256
ff6d5e742455c96504a7a58523e15414997bb596db8f22e2c3e1e53b48f9b5ea

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001595248.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))